Regentis Biomaterials Ltd. (RGNT): Operating Cash Flow

Annual figures by period end, from SEC filings.

-$1.38M

Year ended 2025-12-31

2023-12-31 Operating Cash Flow (USD) 2025-12-31

Period ended	Operating Cash Flow	Change YoY	Source filing
2025-12-31	-$1.38M	n/m	2026-02-27, From 2025-01-01
2024-12-31	-$641.0K	n/m	2026-02-27, From 2024-01-01
2023-12-31	-$1.22M	n/a	2026-02-27, From 2023-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Orthopedic, Prosthetic & Surgical Appliances & Supplies), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Operating Cash Flow	Change YoY
Regentis Biomaterials Ltd. (RGNT)	2025-12-31	-$1.38M	n/m
NutriBand Inc. (NTRB)	2026-01-31	-$5.13M	n/m
Milestone Scientific Inc. (MLSS)	2025-12-31	-$2.92M	n/m
Envoy Medical, Inc. (COCH)	2025-12-31	-$18.20M	n/m
Bone Biologics Corp (BBLG)	2025-12-31	-$2.69M	n/m
CollPlant Biotechnologies Ltd (CLGN)	2025-12-31	-$9.42M	n/m
Safe Pro Group Inc. (SPAI)	2025-12-31	-$6.22M	n/m
Vicarious Surgical Inc. (RBOT)	2025-12-31	-$45.08M	n/m
LogicMark, Inc. (LGMK)	2025-12-31	-$5.06M	n/m

Compare RGNT, NTRB, MLSS, COCH side by side · Screen every company in Orthopedic, Prosthetic & Surgical Appliances & Supplies ↗